about
Developmentally distinct in vivo effects of FSH on proliferation and apoptosis during testis maturationNon-essential role for TLR2 and its signaling adaptor Mal/TIRAP in preserving normal lung architecture in miceThe effect of testosterone, dihydrotestosterone and oestradiol on the re-initiation of spermatogenesis in the adult photoinhibited Djungarian hamsterHormonal regulation of male germ cell development.IL6 Trans-signaling Promotes KRAS-Driven Lung Carcinogenesis.Transcriptional regulation of inflammasome-associated pattern recognition receptors, and the relevance to disease pathogenesis.Differential involvement of gp130 signalling pathways in modulating tobacco carcinogen-induced lung tumourigenesis.Therapeutic Targeting of the IL-6 Trans-Signaling/Mechanistic Target of Rapamycin Complex 1 Axis in Pulmonary Emphysema.Blockade of the IL-6 trans-signalling/STAT3 axis suppresses cachexia in Kras-induced lung adenocarcinoma.Deoxyribonuclease 1 reduces pathogenic effects of cigarette smoke exposure in the lungIL-6/Stat3-driven pulmonary inflammation, but not emphysema, is dependent on interleukin-17A in mice.Interleukin-6 promotes pulmonary emphysema associated with apoptosis in mice.Gonadotrophins regulate germ cell survival, not proliferation, in normal adult men.Follicle-stimulating hormone affects spermatogonial survival by regulating the intrinsic apoptotic pathway in adult rats.Inflammasome adaptor ASC suppresses apoptosis of gastric cancer cells by an IL-18 mediated inflammation-independent mechanism.Tissue Processing for Stereological Analyses of Lung Structure in Chronic Obstructive Pulmonary Disease.Pathways involved in testicular germ cell apoptosis in immature rats after FSH suppression.Deregulated Stat3 signaling dissociates pulmonary inflammation from emphysema in gp130 mutant miceTumor Cell Response to Synchrotron Microbeam Radiation Therapy Differs Markedly From Cells in Normal TissuesLung DiseasesADAM17 selectively activates the IL-6 trans-signaling/ERK MAPK axis in KRAS-addicted lung cancerPirfenidone: Molecular Mechanisms and Potential Clinical Applications in Lung Disease
P50
Q28566989-DF50FF6D-782D-4B17-98E7-1CE1AD6EE242Q35036025-36DB7F0F-D24C-45F9-B5D3-FE3F6A049920Q36014455-A7C383B4-C31D-47C6-A788-94C9D7FDA1CDQ37690032-789D584A-50FE-4339-A36F-210B2C87E7ABQ38805619-7F381E0C-6250-44F4-BA9A-EBAA19ADC594Q38970985-9C0F9425-04E7-4C52-BBB7-73A3D8095803Q39004659-6B4F1D71-0527-4F65-81FA-2F96292C688FQ39635639-877666A8-3C73-4E05-8950-083EE1CBDA97Q40433122-921B64DD-F55E-4CCC-BEBC-51601FE04A6DQ41995397-8951D3BB-4A7E-4286-BAAC-1D4BE8312AA8Q42229349-8ABE1E1F-BB88-4D19-85CB-66FABA21050EQ44769698-988BDDEF-E1C8-4528-B525-19F5D066FCF9Q46804938-44854D57-D88C-479A-819D-9D5C760C6B40Q46840550-786D5F07-BC98-4F83-B60A-181F1E120AB7Q47251171-75A757AF-86E6-4AF6-9C86-33B1A7979CB9Q50097613-36169DB4-523D-4BDB-A384-452E6E22F387Q53488712-9D1FA0EA-7650-4FDD-BC82-9CABD5603D07Q57651552-364D4829-51FB-4FAC-9A75-2F5EF2B6F436Q58665506-A1F34EAD-1B53-4CDF-8C0A-903A6FF3EB80Q60543392-13EC81CB-AD9A-463C-9F8D-2F57CA16CAFBQ64067287-F20D729E-3C2E-4354-AF7B-DB6F888948B8Q92848683-95B1F20C-1750-4D5C-A3F0-30991CC97E36
P50
description
investigador
@es
researcher
@en
name
Saleela M Ruwanpura
@en
Saleela M Ruwanpura
@nl
type
label
Saleela M Ruwanpura
@en
Saleela M Ruwanpura
@nl
prefLabel
Saleela M Ruwanpura
@en
Saleela M Ruwanpura
@nl
P108
P31
P496
0000-0002-4074-2012